Ligand Pharmaceuticals Inc (LGND)

01:03 AM

How supply chain issues affect Ligand Pharmaceuticals Incorporated stockMarket Risk Summary & Stepwise Trade Execution Plans - newser.com

01:03 AM

12:37 PM

What catalysts could drive Ligand Pharmaceuticals Incorporated stock higher2025 Price Action Summary & Real-Time Price Movement Reports - newser.com

12:37 PM

Nov 04, 2025

Is Ligand Pharmaceuticals Incorporated forming a reversal patternWeekly Stock Report & Real-Time Sentiment Analysis - newser.com

Nov 04, 2025

Nov 04, 2025

Ligand Pharmaceuticals (NASDAQ:LGND) Price Target Raised to $250.00 at Oppenheimer - MarketBeat

Nov 04, 2025

Nov 04, 2025

Will breakout in Ligand Pharmaceuticals Incorporated lead to full recoveryWeekly Risk Summary & Precise Swing Trade Alerts - newser.com

Nov 04, 2025

Nov 04, 2025

Oppenheimer Maintains Ligand Pharmaceuticals IncorporatedEquity Right (LGNXZ) Outperform Recommendation - Nasdaq

Nov 04, 2025

Nov 04, 2025

How Ligand Pharmaceuticals Incorporated (LGDN) stock compares with market leadersJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com

Nov 04, 2025

Nov 04, 2025

Is Ligand Pharmaceuticals Incorporated reversing from oversold territoryQuarterly Portfolio Report & Advanced Swing Trade Entry Plans - newser.com

Nov 04, 2025

Nov 04, 2025

Intraday pattern recognizer results for Ligand Pharmaceuticals Incorporated2025 Top Gainers & Daily Oversold Bounce Ideas - newser.com

Nov 04, 2025

Nov 04, 2025

Will Ligand Pharmaceuticals Incorporated (LGDN) stock announce a stock splitMarket Sentiment Summary & Safe Entry Zone Tips - newser.com

Nov 04, 2025

Nov 03, 2025

Oppenheimer Raises Price Target for Ligand Pharmaceuticals (LGND) to $250 | LGND Stock News - GuruFocus

Nov 03, 2025

Nov 03, 2025

How to use Fibonacci retracement on Ligand Pharmaceuticals Incorporated2025 Market WrapUp & Precise Buy Zone Identification - newser.com

Nov 03, 2025

Nov 03, 2025

Oppenheimer Maintains Ligand Pharmaceuticals (LGND) Outperform Recommendation - Nasdaq

Nov 03, 2025

Nov 03, 2025

How Investors Are Reacting To Ligand Pharmaceuticals (LGND) Management's Engagement Surge and Analyst Optimism - Yahoo Finance

Nov 03, 2025

Nov 03, 2025

Oppenheimer Raises Price Target on Ligand Pharmaceuticals to $250 From $190, Keeps Outperform Rating - MarketScreener

Nov 03, 2025

Nov 03, 2025

Will Ligand Pharmaceuticals Incorporated (LGDN) stock hit analyst forecastsTrade Exit Summary & Detailed Earnings Play Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Can Ligand Pharmaceuticals Incorporated stock sustain market leadership2025 Support & Resistance & Daily Profit Focused Stock Screening - newser.com

Nov 03, 2025

Nov 03, 2025

Is Ligand Pharmaceuticals Incorporated (LGDN) stock attractive post correctionJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com

Nov 03, 2025

Nov 03, 2025

Short interest data insights for Ligand Pharmaceuticals Incorporated2025 Technical Patterns & Long-Term Growth Portfolio Plans - newser.com

Nov 03, 2025

Nov 03, 2025

What institutional flow reveals about Ligand Pharmaceuticals IncorporatedWeekly Profit Recap & Free Long-Term Investment Growth Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Analyzing drawdowns of Ligand Pharmaceuticals Incorporated with statistical toolsPortfolio Growth Summary & Accurate Buy Signal Notifications - newser.com

Nov 03, 2025

Nov 03, 2025

What moving averages say about Ligand Pharmaceuticals Incorporated2025 Trading Recap & Technical Entry and Exit Alerts - newser.com

Nov 03, 2025

Nov 02, 2025

Published on: 2025-11-02 23:44:20 - newser.com

Nov 02, 2025

Nov 02, 2025

Does Ligand Pharmaceuticals Incorporated show high probability of reboundWeekly Stock Analysis & Daily Growth Stock Investment Tips - newser.com

Nov 02, 2025

Oct 31, 2025

Technical signs of recovery in Ligand Pharmaceuticals Incorporated2025 Trade Ideas & Fast Gain Stock Tips - newser.com

Oct 31, 2025